Cerebral thrombosis associated with heterozygous factor V Leiden mutation and high lipoprotein(a) level in a girl with factor XIII deficiency

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 4, 2007, Pages 371-374

  Akbalk, Mehtap ^a   Duru, Feride ^a   Fisgin, Tunc ^a   Tasdemir, Haydar Ali ^a   Incesu, Lutfi ^a   Albayrak, Davut ^a   Ozyurek, Emel ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Factor V Leiden mutation; Factor XIII deficiency; Lipoprotein(a)

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; DROWSINESS; FEMALE; GENETIC RISK; HETEROZYGOTE; HUMAN; INTRACRANIAL PRESSURE; LIPOPROTEIN BLOOD LEVEL; LUMBAR PUNCTURE; MAGNETIC RESONANCE ANGIOGRAPHY; OCCLUSIVE CEREBROVASCULAR DISEASE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; STRABISMUS; TONSILLITIS; VEIN THROMBOSIS;

ANTICOAGULANTS; CEREBRAL ANGIOGRAPHY; CHILD, PRESCHOOL; CONSANGUINITY; FACTOR V; FACTOR XIII DEFICIENCY; FEMALE; HETEROZYGOTE; HUMANS; LIPOPROTEIN(A); SAGITTAL SINUS THROMBOSIS; WARFARIN;

EID: 34247890034     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3280d5a7be     Document Type: Article

References (20)

1. Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev 1993; 7:229-242.
2. Egbring R, Kroniger A, Seitz R. Factor XIII deficiency: pathogenic mechanisms and clinical significance. Semin Thromb Hemost 1996; 107:468-484.
3. Anwar R, Miloszewski JA. Factor XIII deficiency. Br J Haematol 1999; 107:468-484.
4. Al-Sharif FZ, Aljurf MD, Al-Momen AM, Ajlan AM, Musa MO, Al-Nounou RM, et al. Clinical and laboratory features of congenital factor XIII deficiency. Saudi Med J 2002; 23:552-554.
5. Garcia Arqueza C, Gutierrez Benjumea A, Aguayo Maldonado J, Almuedo Paz A. Cephalohemoatoma as the first manifestation of congenital factor XIII deficiency. Ann Esp Pediatr 2000; 53:241-242.
6. Jennings I, Kitchen S, Woods TA, Preston FE. UK NEQAS. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003; 1:2603-2608.
7. Dahlback B. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Semin Hematol 1997; 34:217-234.
8. Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997; 39:313-315.
9. Gurgey A. Clinical manifestations in thrombotic children with factor V Leiden mutation. Pediatr Hematol Oncol 1999; 16:233-237.
10. von Depka M, Nowak-Göttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thrombosis. Blood 2000; 96:3364-3368.
11. Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94:3678-3682.
12. Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr, Simari RD. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001; 98:2980-2987.
13. Ehrenforth S, Junker R, Koch HG, Kreuz W, Munchow N, Scharrer I, Nowak-Gottl U. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr 1999; 158 (Suppl 3):97-104.
14. Maruki C, Nakajima M, Tsunoda A, Ebato M, Ikeya F. A case of giant expanding cephalhematoma: does the administration of blood coagulation factor XIII reverse symptoms? Surge Neurol 2003; 60:138-141.
15. Albanese A, Tuttolomondo A, Anile C, Sabatino G, Pompucci A, Pinto A, et al. Spontaneous chronic subdural hematomas in young adults with a deficiency in coagulation factor XIII. Report of three cases. J Neurosurg 2005; 102:1130-1132.
16. Olcay L, Gurgey A, Topaloglu H, Altay S, Parlak H, Firat M. Cerebral infarct associated with factor V Leiden mutation in a boy with hemophilia A. Am J Hematol 1997; 56:189-190.
17. Ichinose A, Maruyama I, Yoshida Y, Igata A. Cerebral thrombosis in a hemophiliac [letter]. Thromb Haemost 1981; 45:190.
18. Shebuski RJ, Sitko GR, Claremon DA, Baldwin JJ, Remy DC, Stern AM. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. Blood 1990; 75:1455-1459.
19. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93:906-908.
20. Riela AR, Roach ES. Etiology of stroke in children. J Child Neurol 1993; 8:201-220.